– Combined Puraxel AESTHETIC Er: YAG LASER
with Nuvogen Orchestra provides skin rejuvenation treatment, result in younger looking and better skin. Effects go to the epidermis layer in a non-invasive way, no pain. What the Magic!
– Xspurt HA Filler give volumization contouring while Secret Plus+ High Indensity Focused Ultrasound System gives Face V-Lifting(Deep into your skin). Amazing Effect!
Experince: 10 Years
FHL-101 is a small molecule derived from natural ingredients that promotes dopaminergic activity by maintaining sustained levels of proteins and neurotransmitters necessary for protection of dopaminergic neurons.
FHL-801 is a neutralizing antibody which protects dopaminergic neurons and reduces inflammation by inhibiting RANTES and eotaxin.
FHL-501 is a novel peptide which inhibits the NK-FB pathway to reduce inflammation and protect dopaminergic neurons.
– Secret Plus+ High Indensity Focused Ultrasound System gives Face V-Lifting(Deep into your skin) while Xspurt HA Filler give volumization contouring . Amazing Effect!
– Combined Nuvogen Orchestra with Puraxel AESTHETIC ER: YAG LASER provides skin rejuvenation treatment, result in younger looking and better skin. Effects go to the epidermis layer in a non-invasive way, no pain. What the Magic!
– Combined Nuvogen Duet with DermaShine Pro gives more volumization and provides skin regeneration treament. Both Filling Serum and Digital Micro-Needle Injector are in medical grade. Keep Safe!
– Combined DermaShine Pro with Nuvogen Duet gives more volumization and provides skin regeneration treament. Both Filling Serum and Digital Micro-Needle Injector are in medical grade. Keep Safe!
FHL-301 is a repurposed drug, a synthetic agonist of PPAR-Alpha helps in reducing inflammation and glial activation.
FHL-201 is another small molecule derived from natural ingredients and basically an endogenous ligand of PPAR-Alpha works by restoring striatal neuro transmitters and motor functions.
FHL-701 is a monoclonal antibody which inhibits an IL-12 subtype and has been shown to reduce the amyloid plaque load in the hippocampus, a significant marker for Alzheimer’s Disease.
FHL-601 is a repurposed drug which prevents damage of dopaminergic neurons by blocking CCR5 receptor and preventing T-cell infiltration, endorsed by anti-inflammatory mechanism of action.
FHL-401 isa novel peptide which protects the dopaminergic neurons by blocking the spread of synuclein associated pathology and inflammation by interfering with TLR-2- MyD88 signals.
